Negotiated Procedure Pursuant To Art. 76, Paragraph 2 Letter. B) Of The Legislative Decree. 36/2023 And Subsequent Amendments. For The Annual Supply Of The Medicinal Specialty Referred To In The Following Active Ingredient "Pralidoxime Methylsulphate" Injectable Solution 200 Mg/10 Ml, Atc V03Ab04 - Aic 021091020.